ERBB2 and breast neoplasm: Recent studies also demonstrated that CD47 transcription is regulated via HER2–NF-κB pathway, and antibody-mediated blockage of both CD47 and HER2 synergized with radiotherapy for the treatment of syngeneic mouse breast tumors.